| Value | ₹0.01 Cr |
|---|
BSE filing, NSE: ENTERO. Summary written from the filing by ALFA Finder's alert engine.
Entero Healthcare Solutions Ltd: key numbers
- Share price
- ₹1,572.10
- Market cap
- ₹6,849 Cr
- Revenue (annual)
- ₹6,591 Cr
- Net profit (annual)
- ₹115.0 Cr
- P/E (TTM)
- 54.6×Sector 53.7×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 5.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Entero Healthcare Solutions Ltd
All →Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing reports promoter and public holdings, with no transaction or corporate event.
Entero Healthcare Solutions Board Meeting Date
Entero Healthcare Solutions scheduled a board meeting for November 04, 2026, to consider and approve unaudited financial results for the quarter ended September 30, 2026.
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 2026.
Entero Healthcare Solutions Employee Stock Options
Entero Healthcare allotted 43,155 equity shares to employees upon exercise of stock options. The total consideration amounts to ₹4.24 Crore.
- Value
- ₹4.24 Cr
Entero Healthcare Solutions Capital Structure Change
Surbhi Singh (Prasid Uno Family Trust), a non-promoter, sold 21.30 lakh Entero Healthcare shares via bulk/block deals. Stake fell from 7.94% to 3.05%; no transaction value disclosed.
Entero Healthcare Solutions Legal & Regulatory
Entero Healthcare Solutions reported a GST penalty of Rs. 0.13 Crore imposed on its subsidiary, ACE Cardiopathy Solutions, for non-generation of an E-Invoice.
- Value
- ₹0.13 Cr
Other merger & restructuring announcements
All →Hinduja Global Solutions Merger & Restructuring
Hinduja Global Solutions updated on its subsidiary IMCL's plan to sell its entire stake in Bhima Riddhi and Vinsat to external buyers. Completion is taking longer, and both will cease to be step-down subsidiaries on completion.
Ganesh Benzoplast Merger & Restructuring Worth ₹1,066 Cr
Ganesh Benzoplast seeks shareholder approval via postal ballot for a Rs 1,066 Crore slump sale of its liquid storage terminal business to Cisternina Logistics, and a rail logistics business transfer. E-voting runs 6 November to 5 December 2026.
- Value
- ₹1,066 Cr
Ceigall India Merger & Restructuring Worth ₹86.32 Cr
Ceigall India Ltd will infuse Rs. 86.32 Crore into its step-down subsidiary, Ceigall Ambala Chandigarh Zirakpur Limited. The investment supports a 6-lane spur connectivity highway project in Punjab.
- Value
- ₹86.32 Cr
- highway length
- 10.3 Km
Computer Age Management Services Merger & Restructuring
CAMS disclosed the voluntary liquidation and dissolution of its non-material step-down subsidiary Think Analytics under IBC Section 59. The closure has no impact on company operations.
India Glycols Merger & Restructuring
India Glycols disclosed that IGL Spirits received BSE and NSE listing approval for 6.70 crore demerger shares. Trading in these equity shares begins on 4 November 2026.
Kaynes Technology India Merger & Restructuring Worth ₹0.25 Cr
Kaynes Technology will incorporate Kaynes Arabia Electronics Company in Saudi Arabia, holding 100% for electronics manufacturing for GCC markets. Cash consideration is Rs. 0.25 Crore, funded through multiple tranches.
- Value
- ₹0.25 Cr